Mason District Hospital
Havana, Illinois, United States
Hospital in Havana, Illinois
615 N Promenade St, Havana, IL 62644
About Mason District Hospital
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Alliance for Clinical Trials in Oncology
77
National Cancer Institute (NCI)
61
SWOG Cancer Research Network
13
Eastern Cooperative Oncology Group
11
NSABP Foundation Inc
8
Radiation Therapy Oncology Group
7
ECOG-ACRIN Cancer Research Group
6
GOG Foundation
2
ETOP IBCSG Partners Foundation
1
Mayo Clinic
1
North Central Cancer Treatment Group
1
Clinical Trials at Mason District Hospital
During the past decade, Mason District Hospital conducted 0 clinical trials. In the 10-year time frame, 0 clinical trials started and 99 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 0 clinical trials started and 13 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Combination Chemotherapy With or Without Radiation Therapy in Treating Patients With Hodgkin's Lymphoma
1999-04-01
2016-05-01
Completed
854
S9811 Hydroxyurea in Treating Patients With Unresectable Benign Meningioma
1998-11-01
2011-07-01
Completed
29
Combination Chemotherapy in Treating Patients With Advanced Colorectal Cancer
1998-10-01
2004-10-01
Completed
1,691
Chemotherapy Plus Radiation Therapy in Treating Patients With Stage II or Stage III Anal Cancer
1998-10-01
2016-12-01
Completed
682
Radiation Therapy Combined With Chemotherapy in Treating Patients With Anaplastic Astrocytoma or Mixed Gliomas
2000-06-01
2018-05-14
Completed
230
Combination Chemotherapy and Radiation Therapy in Treating Patients With Limited-Stage Small Cell Lung Cancer
2001-02-01
2006-05-01
Completed
73
S0008: Chemotherapy Plus Biological Therapy in Treating Patients With Melanoma
2000-08-01
2012-07-01
Completed
432
S0016 Combination Chemotherapy With Monoclonal Antibody Therapy in Newly Diagnosed Non-Hodgkin's Lymphoma
2001-03-01
2023-06-01
Active, not recruiting
571
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Mason District Hospital" #1 sponsor was "Alliance for Clinical Trials in Oncology" with 77 trials, followed by "National Cancer Institute (NCI)" with 61 trials
sponsored, "SWOG Cancer Research Network" with 13 trials sponsored, "Eastern Cooperative Oncology Group" with 11 trials sponsored and "NSABP Foundation Inc"
with 11 trials sponsored. Other sponsors include 14 different institutions and
companies that sponsored additional 12 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Mason District Hospital"
#1 collaborator was "National Cancer Institute (NCI)" with 128 trials as a collaborator, "NCIC Clinical Trials Group" with 14 trials as a collaborator, "Cancer and Leukemia Group B" with 12 trials as a collaborator, "Eastern Cooperative Oncology Group" with 11 trials as a collaborator and "NRG Oncology" with 11 trials as a collaborator. Other collaborators include 31 different institutions and companies that were
collaborators in the rest 20 trials.
Clinical Trials Conditions at Mason District Hospital
According to Clinical.Site data, the most researched conditions in "Mason District Hospital" are
"Breast Cancer" (28 trials), "Lung Cancer" (18 trials), "Lymphoma" (14 trials), "Unspecified Adult Solid Tumor, Protocol Specific" (12 trials) and "Leukemia" (8 trials). Many other conditions were trialed in "Mason District Hospital" in a lesser frequency.
Clinical Trials Intervention Types at Mason District Hospital
Most popular intervention types in "Mason District Hospital" are "Drug" (163 trials), "Other" (78 trials), "Biological" (77 trials), "Radiation" (31 trials) and "Procedure" (16 trials). Other intervention types were less common.
The name of intervention was led by "Laboratory Biomarker Analysis" (41 trials), "placebo" (23 trials), "Bevacizumab" (17 trials), "Paclitaxel" (16 trials) and "carboplatin" (16 trials). Other intervention names were less common.
Clinical Trials Genders at Mason District Hospital
The vast majority of trials in "Mason District Hospital" are
149 trials for "All" genders, 35 trials for "Female" genders and 5 trials for "Male" genders.
Clinical Trials Status at Mason District Hospital
Currently, there are NaN active trials in "Mason District Hospital".
undefined are not yet recruiting,
undefined are recruiting,
37 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 137 completed trials in Mason District Hospital,
undefined suspended trials,
and 13 terminated clinical trials to date.
Out of the total trials that were conducted in Mason District Hospital, 12 "Phase 1"
clinical trials were conducted, 89 "Phase 2" clinical
trials and 91 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".